Drinking green tea is safe for most people but consuming large amounts may raise the risk of iron deficiency anemia, liver problems, and drug interactions ...
The Healthy @Reader's Digest on MSN

5 Signs of Colon Cancer Every Woman Should Know

Colon cancer symptoms in women are similar to those in men, but they can be confused with gynecological issues, like cramping ...
Skin conditions, diet choices, and some chronic health conditions may make the bottom of your feet yellow. Treating the cause ...
Shares of Akebia Therapeutics fell sharply premarket after it abandoned plans for a clinical trial of its anemia treatment in patients not on kidney dialysis following a meeting with the Food and Drug ...
The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...
Ascentage Pharma Group International (($HK:6855)) announced an update on their ongoing clinical study. Study Overview: Ascentage Pharma Group Inc.
Researchers have developed a new iron supplement that pairs iron with prebiotics and probiotics to improve absorption and reduce side effects. Iron-deficiency anemia is a widespread condition that ...
Her treatment plan, including transfusions and medication ... Doctors diagnosed Davis with warm autoimmune hemolytic anemia, ...
While blockbuster drug innovations have changed health outcomes for decades, we’re now seeing signs that GLP-1 medications like Ozempic and Wegovy may be changing something broader: the consumer ...
Dr. Jeffrey L. Schnipper is a hospitalist, research director of the division of general internal medicine and primary care at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical ...
CINCINNATI — Weight loss drugs like Ozempic and Wegovy just became significantly more affordable, with savings of nearly $1,000 per month available at Costco. But doctors say there's an important ...
Almost every Senate Republican on Thursday urged the Food and Drug Administration (FDA) to “reevaluate” whether a newly approved generic version of the abortion drug mifepristone should stay on the ...